ePT--the Electronic Newsletter of Pharmaceutical Technology, Dec 6, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Dec 6, 2012
News
Ranbaxy Issues Voluntary Recall of Atorvastatin Due to Quality Issues
By Patricia Van Arnum
The company issues voluntary recall of certain lots due to possible contamination with small glass particles.
EMA Publishes Plan to Deal with Supply Shortages
By Stephanie Sutton
The European Medicines Agency has published a plan to help Europe?s regulatory network prevent, mitigate and manage shortages of important medicines following manufacturing problems.
US Supreme Court to Hear Myriad Genetics' Gene Patentability Case
By Patricia Van Arnum
Myriad Genetics reports that the US Supreme Court has granted certiorari agreeing to hear the company's gene patentability case.
Lilly Releases Corporate Responsibility Update
By Amy Ritter
Eli Lilly released its annual report containing updates on progress and new initiatives in corporate responsibility.
Week of December 3, 2012: Biogen Idec Opens New RTP Facility; Tekmira, Marina Biotech Enter into License Agreement for UNA Technology; and More
Biogen Idec Opens New RTP Facility; Tekmira, Marina Biotech Enter into License Agreement for UNA Technology; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here